zilovertamab vedotin in the treatment of mantle cell lymphoma
Published 2 years ago • 512 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:24
treatment methods in mantle cell lymphoma
-
1:33
developing mantle cell lymphoma treatment for further success
-
1:44
treating mantle cell lymphoma: past approaches and future perspectives
-
2:09
recent investigational advances in mantle cell lymphoma treatment
-
2:07
novel treatments for mantle cell lymphoma
-
4:31
a risk-adapted treatment approach for mantle cell lymphoma
-
0:58
therapies under investigation for mantle cell lymphoma
-
2:00
glofitamab: a valuable agent for the treatment of patients with r/r mantle cell lymphoma
-
10:42
understanding mantle cell lymphoma with jia ruan, md, ph.d.
-
1:33
tumor-infiltrating lymphocyte therapy (til) video credit: iovance biotherapeutics
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:09
the optimal sequencing of novel therapies in mantle cell lymphoma
-
2:27
ash 2014: novel treatments for mantle cell lymphoma
-
5:06
trials of interest in the mantle cell lymphoma space at ash 2023
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
1:38
the uk treatment landscape of mantle cell lymphoma
-
2:43
interim analysis of the elm-2 study: odronextamab in patients with r/r follicular lymphoma
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:31
new therapies for mantle cell lymphoma
-
9:26
phase i/ii study of zilovertamab and ibrutinib in mcl and cll
-
1:05
where do bispecific antibodies fit into the large cell lymphoma treatment landscape?
-
1:32
assessing the dynamics of cd8-expressing cells in patients with r/r lbcl treated with glofitamab